PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 4:58 AM ET

Sponsor Check › Person

CC
No photo found yet (own website and image search run after this page is viewed)

Chris Chapman

Named as an officer, director or promoter on SEC Form D filings · MD, FL · Aug 1, 2022 → May 31, 2024

3deals (issuers)
$34.4Mreported sold
142investors
6Form D filings
2022–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:53 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Chris Chapman is listed as an executive officer and director on 6 SEC Form D filings by 3 issuers between Aug 2022 and May 2024: TNF Pharmaceuticals, Inc. (New York, NY — pharmaceuticals — 2022–2024; $26.9M reported sold to 56 investors), Mira1a Therapeutics, Inc. (Baltimore, MD — pharmaceuticals — 2022; $6.51M reported sold to 76 investors) and Telomir Pharmaceuticals, Inc. (Tampa, FL — pharmaceuticals — 2023; $1M reported sold to 10 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 2 years. Across those companies the filings report $34.4M sold in total.

Listed alongside Jude Uzonwanne (6 shared filings), Craig Eagle (4 shared filings), Adam Kaplin, MD, PhD (3 shared filings), Bill J. White (3 shared filings), Christopher C. Schreiber (3 shared filings) and 12 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Chris. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 9 bankruptcy cases matching the name listed in Key records below.

What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 6 public filings for Chris Chapman and found 9 differences, 1 worth asking the sponsor about: Form D filed 265 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Chris Chapman has not run yet — it is joining a line of 3,046 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:53 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Chris Chapman..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

9 cases: 9 closed (disposition not in docket feed)

Chris E Chapman closed
United States Bankruptcy Court, D. North Dakota · No. 10-30957 · Filed Jul 30, 2010 · Closed Dec 1, 2010
Role of Chris E Chapman: Debtor · Outcome: Case closed 2010-12-01 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in ND (not a filing state)
Chris M. Chapman closed
United States Bankruptcy Court, N.D. Alabama · No. 08-70295 · Filed Feb 14, 2008 · Closed Jun 17, 2013
Role of Chris M. Chapman: Debtor · Outcome: Case closed 2013-06-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in AL (not a filing state)
Chris L Chapman closed
United States Bankruptcy Court, N.D. Illinois · No. 06-16023 · Filed Dec 5, 2006 · Closed Mar 8, 2007
Role of Chris L Chapman: Debtor · Outcome: Case closed 2007-03-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in IL (not a filing state)
Chris A. Chapman closed
United States Bankruptcy Court, N.D. Georgia · No. 04-13767 · Filed Nov 17, 2004 · Closed Mar 3, 2005
Role of Chris A. Chapman: Debtor · Outcome: Case closed 2005-03-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in GA (not a filing state)
Chris Chapman and Tammy Chapman closed
United States Bankruptcy Court, N.D. Alabama · No. 04-41684 · Filed May 17, 2004 · Closed Jun 17, 2010
Role of Chris Chapman and Tammy Chapman: Debtor · Outcome: Case closed 2010-06-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in AL (not a filing state)
Chris R. Chapman and Melanie Chapman closed
United States Bankruptcy Court, D. Oregon · No. 03-40863 · Filed Sep 25, 2003 · Closed Feb 11, 2004
Role of Chris R. Chapman and Melanie Chapman: Debtor · Outcome: Case closed 2004-02-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in OR (not a filing state)
Chris D. Chapman and Cathy S. Chapman closed
United States Bankruptcy Court, W.D. New York · No. 2-99-22378 · Filed Aug 2, 1999 · Closed Nov 29, 1999
Role of Chris D. Chapman and Cathy S. Chapman: Debtor · Outcome: Case closed 1999-11-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in the person's filing state (NY)
Chris Chapman and Maxine Chapman closed
United States Bankruptcy Court, W.D. Tennessee · No. 98-13695 · Filed Sep 29, 1998 · Closed May 5, 2000
Role of Chris Chapman and Maxine Chapman: Debtor · Outcome: Case closed 2000-05-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in TN (not a filing state)
CHRIS A. CHAPMAN and SHANNON L. CHAPMAN closed
United States Bankruptcy Court, N.D. Alabama · No. 85-02832 · Filed May 6, 1986 · Closed Nov 12, 1985
Role of CHRIS A. CHAPMAN and SHANNON L. CHAPMAN: Debtor · Outcome: Case closed 1985-11-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); court in AL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:53 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

9 differences found between the filings for Chris Chapman — 1 worth asking about (compared 6 filings on Oct 24, 2026)

Worth asking · Nov 9, 2021 – Aug 1, 2022

Form D filed 265 days after the first sale — Mira1a Therapeutics, Inc.

The filing says the first sale was Nov 9, 2021. The Form D was filed Aug 1, 2022 — 265 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 250 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Note · Mar 15, 2023 – Apr 3, 2023

Form D filed 19 days after the first sale — Telomir Pharmaceuticals, Inc.

The filing says the first sale was Mar 15, 2023. The Form D was filed Apr 3, 2023 — 19 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 4 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Aug 30, 2022 – May 31, 2024

Chris Chapman's role changed at TNF Pharmaceuticals, Inc.: executive officer, director → executive officer

The Aug 30, 2022 filing lists Chris Chapman as executive officer, director; the May 31, 2024 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Aug 15, 2022 – Aug 30, 2022

No amendment in the last 12 months on an offering that may still be open — TNF Pharmaceuticals, Inc. (latest filing Aug 30, 2022)

The latest filing for this offering is dated Aug 30, 2022 (first sale Aug 15, 2022). It reports $0 sold of $7,411,761 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jul 22, 2022 – Aug 1, 2022

No amendment in the last 12 months on an offering that may still be open — Mira1a Therapeutics, Inc. (latest filing Aug 1, 2022)

The latest filing for this offering is dated Aug 1, 2022 (first sale Jul 22, 2022). It reports $625,000 sold of $3,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Aug 1, 2022 – Aug 30, 2022

Chris Chapman is written 2 different ways on the filings

listed as "Chris Chapman, MD" on 2 filings (from Aug 1, 2022), and "Chris Chapman" on 4 filings (from Aug 30, 2022).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Aug 30, 2022 – May 31, 2024

Industry group changed between filings — TNF Pharmaceuticals, Inc.

"Other Health Care" (Aug 30, 2022); then "Pharmaceuticals" (May 31, 2024 to May 31, 2024).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Aug 30, 2022

Formed in 2023 per the latest filing, but activity is dated 2022 — TNF Pharmaceuticals, Inc.

The issuer's latest filing says it was formed in 2023. The Aug 30, 2022 filing says the first sale was Aug 15, 2022 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

5 of 6 offerings report sales commissions totalling $1,461,999; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
May 31, 2024 D
TNF Pharmaceuticals, Inc.
File 021-514757
$537,000$0$0Palladium Capital Group, LLC BrokerCheck CRD 000129400 ↗
GP Nurmenkari Inc. BrokerCheck CRD 000153480 ↗
EDGAR ↗
May 31, 2024 D
TNF Pharmaceuticals, Inc.
File 021-514758
$303,000$0$0Palladium Capital Group, LLC BrokerCheck CRD 000129400 ↗
GP Nurmenkari Inc. BrokerCheck CRD 000153480 ↗
EDGAR ↗
Apr 3, 2023 D
Telomir Pharmaceuticals, Inc.
File 021-477688
$90,000$0$0Skyway Capital Markets, LLC BrokerCheck CRD 124630 ↗EDGAR ↗
Aug 30, 2022 D
TNF Pharmaceuticals, Inc.
File 021-457338
$239,999$0$0Dawson James Securities, Inc. BrokerCheck CRD 130645 ↗EDGAR ↗
Aug 1, 2022 D
Mira1a Therapeutics, Inc.
File 021-454387
$292,000$0$0Skyway Capital Markets BrokerCheck CRD 124630 ↗EDGAR ↗
Aug 1, 2022 D
Mira1a Therapeutics, Inc.
File 021-454401
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Chris Chapman on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pharmaceuticals

TNF Pharmaceuticals, Inc.

New York, NY · Aug 30, 2022 → May 31, 2024 · 3 filings
  • May 31, 2024 · D · $15,150,007 sold of $15,150,007 · 5 investors · min. No minimum reported · role: Executive Officer (President, Chief Medical Officer, and Director) EDGAR ↗
  • May 31, 2024 · D · $26,850,006 sold of $26,850,006 · 4 investors · min. No minimum reported · role: Executive Officer (President, Chief Medical Officer, and Director) EDGAR ↗
  • Aug 30, 2022 · D · $0 sold of $7,411,761 · 8 investors · min. No minimum reported · role: Executive Officer, Director (Director, President and Chief Medical Officer) EDGAR ↗

Raised $26.9M from 56 investors (100% of the $15.2M target) as of the latest filing. Chris is listed as executive officer, director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Telomir Pharmaceuticals, Inc.

Tampa, FL · Apr 3, 2023
  • Apr 3, 2023 · D · $1,000,000 sold of $1,000,000 · 10 investors · min. No minimum reported · role: Executive Officer, Director (President, Chief Executive Officer and Chairman) EDGAR ↗

Raised $1M from 10 investors (100% of the $1M target) as of the latest filing. Chris is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Mira1a Therapeutics, Inc.

Baltimore, MD · Aug 1, 2022 → Aug 1, 2022 · 2 filings
  • Aug 1, 2022 · D · $625,000 sold of $3,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 1, 2022 · D · $6,511,000 sold of $6,511,000 · 76 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6.51M from 76 investors (100% of the $3M target) as of the latest filing. Chris is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Chris 17

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

JU
No photo found yet (own website and image search run after this page is viewed)
Person

Jude Uzonwanne

Director, Executive Officer · 6 shared filings (3 issuers)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

CE
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Eagle

Director · 4 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Chris Chapman. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

Hugh L. McColl, III

Director · 3 shared filings (2 issuers) · also on 9 other issuers

Hugh L. McColl, III is on 11 issuers in total — a repeat sponsor. Their page lists every one.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Kaplin, MD, PhD

Executive Officer · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Chris Chapman. Their page shows their other deals.

BW
No photo found yet (own website and image search run after this page is viewed)
Person

Bill J. White

Director · 3 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher C. Schreiber

Director · 3 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

IR
No photo found yet (own website and image search run after this page is viewed)
Person

Ian Rhodes

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

PE
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Rivard, ESQ

Executive Officer · 3 shared filings (2 issuers)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James McNulty

Executive Officer · 3 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Chris Chapman. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Joshua Silverman

Director · 3 shared filings (1 issuer) · also on 10 other issuers

Joshua Silverman is on 11 issuers in total — a repeat sponsor. Their page lists every one.

BK
No photo found yet (own website and image search run after this page is viewed)
Person

Brad Kroenig

Director · 2 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

TJ
No photo found yet (own website and image search run after this page is viewed)
Person

Talhia Tuck, JD

Director · 2 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Josh Silverman

Director · 2 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

DV
No photo found yet (own website and image search run after this page is viewed)
Person

Dave Vorhoff

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Chris Chapman. Their page shows their other deals.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell Glass

Director · 2 shared filings (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Tuck Talhia

Director · 1 shared filing (1 issuer)

Listed on the same filings as Chris Chapman. Their page shows their other deals.

DV
No photo found yet (own website and image search run after this page is viewed)
Person

David Vorhoff

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Chris Chapman. Their page shows their other deals.

The team behind the deals

Same business address

10 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Chris Chapman by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Chris Chapman is listed on: none on file. No website or social profile named in Mira1a Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #149,155 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Baltimore, MD). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Chris Chapman appears on a new Form D, or when a court case or SEC action is matched to them. See plans →